Search

Your search keyword '"Frydman, Aviva"' showing total 3 results
Start Over Author "Frydman, Aviva" Journal diabetes care
3 results on '"Frydman, Aviva"'

1. Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes. Diabetes Care 2021;44:e124–e126

Author

Hamblin, Peter S., primary, Wong, Rosemary, additional, Ekinci, Elif I., additional, Sztal-Mazer, Shoshana, additional, Balachandran, Shananthan, additional, Frydman, Aviva, additional, Hanrahan, Timothy P., additional, Hu, Raymond, additional, Ket, Shara N., additional, Moss, Alan, additional, Ng, Mark, additional, Ragunathan, Sashikala, additional, and Bach, Leon A., additional

Published
2021
Full Text
View/download PDF

2. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes

Author

Hamblin, Peter S., primary, Wong, Rosemary, additional, Ekinci, Elif I., additional, Sztal-Mazer, Shoshana, additional, Balachandran, Shananthan, additional, Frydman, Aviva, additional, Hanrahan, Timothy P., additional, Hu, Raymond, additional, Ket, Shara N., additional, Moss, Alan, additional, Ng, Mark, additional, Ragunathan, Sashikala, additional, and Bach, Leon A., additional

Published
2021
Full Text
View/download PDF

3. Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126.

Author

Hamblin, Peter S., Wong, Rosemary, Ekinci, Elif I., Sztal-Mazer, Shoshana, Balachandran, Shananthan, Frydman, Aviva, Hanrahan, Timothy P., Hu, Raymond, Ket, Shara N., Moss, Alan, Ng, Mark, Ragunathan, Sashikala, and Bach, Leon A.

Subjects
TYPE 2 diabetes, COLONOSCOPY, DIABETES, KETONES, CROSS-sectional method
Abstract

The article discusses the capillary ketone concentrations at the time of colonoscopy: a cross-sectional study with implications for SGLT2 inhibitor–treated type 2 diabetes. Topics include procedure centers where there is no access to on-site blood gas analyzers or expertise for dextrose-insulin infusions; and risk of diabetic ketoacidosis (DKA) in SGLT2i-treated people undergoing colonoscopy must be balanced by potential delays in detecting and treating colorectal cancer.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results